Source: Wikipedia, the free encyclopedia.
Protein-coding gene in the species Homo sapiens
SIGLEC7 Gene ontology
Molecular function Cellular component Biological process Sources:Amigo / QuickGO
Wikidata Sialic acid-binding Ig-like lectin 7 is a protein that in humans is encoded by the SIGLEC7 gene .[3] [4] CD328 (cluster of differentiation 328).
References Further reading
Reif K, Buday L, Downward J, Cantrell DA (1994). "SH3 domains of the adapter molecule Grb2 complex with two proteins in T cells: the guanine nucleotide exchange protein Sos and a 75-kDa protein that is a substrate for T cell antigen receptor-activated tyrosine kinases" . J. Biol. Chem . 269 (19): 14081–7. . Falco M, Biassoni R, Bottino C, et al. (1999). "Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells" . J. Exp. Med . 190 (6): 793–802. . Ye X, Mehlen P, Rabizadeh S, et al. (1999). "TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction" . J. Biol. Chem . 274 (42): 30202–8. . Vitale C, Romagnani C, Falco M, et al. (2000). "Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells" . Proc. Natl. Acad. Sci. U.S.A . 96 (26): 15091–6. . Angata T, Varki A (2000). "Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily" . Glycobiology . 10 (4): 431–8. . Ito A, Handa K, Withers DA, et al. (2001). "Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression" . FEBS Lett . 498 (1): 116–20. . Mingari MC, Vitale C, Romagnani C, et al. (2001). "Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors". Progress in Basic and Clinical Immunology . Advances in Experimental Medicine and Biology. Vol. 495. pp. 55–61. . Yousef GM, Ordon MH, Foussias G, Diamandis EP (2002). "Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes". Gene . 286 (2): 259–70. . Alphey MS, Attrill H, Crocker PR, van Aalten DM (2003). "High resolution crystal structures of Siglec-7. Insights into ligand specificity in the Siglec family" . J. Biol. Chem . 278 (5): 3372–7. . Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences" . Proc. Natl. Acad. Sci. U.S.A . 99 (26): 16899–903. . Nicoll G, Avril T, Lock K, et al. (2003). "Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms" . Eur. J. Immunol . 33 (6): 1642–8. . Dimasi N, Moretta A, Moretta L, et al. (2004). "Structure of the saccharide-binding domain of the human natural killer cell inhibitory receptor p75/AIRM1". Acta Crystallogr. D . 60 (Pt 2): 401–3. . Ikehara Y, Ikehara SK, Paulson JC (2004). "Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9" . J. Biol. Chem . 279 (41): 43117–25. . Avril T, Floyd H, Lopez F, et al. (2005). "The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells" . J. Immunol . 173 (11): 6841–9. . Yamaji T, Mitsuki M, Teranishi T, Hashimoto Y (2005). "Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs" . Glycobiology . 15 (7): 667–76. . Attrill H, Takazawa H, Witt S, et al. (2006). "The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design" . Biochem. J . 397 (2): 271–8. . Rapoport EM, Pazynina GV, Sablina MA, et al. (2006). "Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides". Biochemistry Mosc . 71 (5): 496–504. . Biedermann B, Gil D, Bowen DT, Crocker PR (2007). "Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors". Leuk. Res . 31 (2): 211–20. .
PDB gallery
1nko : Energetic and structural basis of sialylated oligosaccharide recognition by the natural killer cell inhibitory receptor p75/AIRM1 or Siglec-7
1o7s : HIGH RESOLUTION STRUCTURE OF SIGLEC-7
1o7v : HIGH RESOLUTION STRUCTURE OF SIGLEC-7
2df3 : The structure of Siglec-7 in complex with alpha(2,3)/alpha(2,6) disialyl lactotetraosyl 2-(trimethylsilyl)ethyl
2g5r : Crystal structure of Siglec-7 in complex with methyl-9-(aminooxalyl-amino)-9-deoxyNeu5Ac (oxamido-Neu5Ac)
2hrl : Siglec-7 in complex with GT1b
External links This article incorporates text from the United States National Library of Medicine , which is in the public domain .
1–50 51–100 101–150 151–200 201–250 251–300 301–350
